close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Co-Dx (CODX) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers CODX
Exposures Financial Product Safety
News headline image
Eton Pharmaceuticals (ETON) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers ETON
Exposures Financial Product Safety
News headline image
Capricor (CAPR) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers CAPR
Exposures Financial Product Safety
Considering Ketamine Therapy? What You Need to Know to Stay Safe
Via Brandpoint
Topics Death
Exposures Death Product Safety
News headline image
Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm to Learn About Their Legal Rights
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
There’s a Black Market for Eli Lilly’s Unapproved GLP-1 Drug. Here’s Why That’s Bullish ↗
Via The Motley Fool
Topics Intellectual Property Lawsuit
Tickers LLY
Exposures Financial Intellectual Property Legal
News headline image
Elutia (ELUT) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers ELUT
Exposures Financial Product Safety
News headline image
Daré Bioscience (DARE) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers DARE
Exposures Financial Product Safety
News headline image
ADC Therapeutics (ADCT) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers ADCT
Exposures Financial Product Safety
News headline image
MDLN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (MDLN) Investors to Contact the Firm
Via NewMediaWire
Tickers MDLN
Exposures Product Safety
TechMediaBreaks – SS Innovations International Inc. (NASDAQ: SSII) Combines Medtech Leadership, Surgeon Training to Drive Robotic Surgery Expansion
Via Investor Brand Network
Tickers SSII
Exposures Product Safety
News headline image
How to choose clinical trial solutions when study risk should drive the decision ↗
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
News headline image
Kaplan Fox Alerts Investors to an Upcoming Deadline of September 28, 2026 in the Capricor Therapeutics, Inc. (NASDAQ: CAPR) Securities Class Action
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Announces an Investigation of Medline Inc. (NASDAQ: MDLN) on Behalf of Investors
Via NewMediaWire
Tickers BAC MDLN
Exposures Product Safety
News headline image
NeuroOne (NMTC) Q3 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers NMTC
Exposures Financial Product Safety
News headline image
Johnson & Johnson Just Sent Shareholders an Important 11-Word Message About Its Future ↗
Via The Motley Fool
Topics Earnings Intellectual Property
Tickers JNJ KVUE
Exposures Financial Intellectual Property Product Safety
News headline image
Cellectar Biosciences (CLRB) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers CLRB
Exposures Financial Product Safety
News headline image
Alvotech Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers ALVO
Exposures Financial Product Safety
News headline image
Ascendis Pharma (ASND) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers ASND
Exposures Financial Product Safety
News headline image
Regeneron Secures FDA Approval For Ultra-Rare Bone Disorder Drug ↗
Via Benzinga
Exposures Product Safety
News headline image
Kaplan Fox is Investigating Potential Securities Law Violations Against Fulcrum Therapeutics, Inc. (NASDAQ: FULC)
Via NewMediaWire
Tickers FULC
Exposures Product Safety
News headline image
Ultragenyx Nabs FDA Nod for First Gene Therapy ↗
Via Benzinga
Exposures Product Safety
News headline image
Ultragenyx Wins FDA Approval for GENGLYCOS, Its First Gene Therapy ↗
Via MarketBeat
Tickers RARE
Exposures Product Safety
News headline image
Biosimulation Market Analysis by Product and Application ↗
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
News headline image
FDA First Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies Noted for Suicidal Bipolar Depression Treatment from NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Tickers NRXP
Exposures Product Safety
News headline image
Trump’s FDA Pick Heidi Overton Faces Republican Resistance as Bill Cassidy Calls Vaccine Order Role ‘Almost Disqualifying’ ↗
Via Benzinga
Topics Government
Exposures Political Product Safety
News headline image
Kaplan Fox & Kilsheimer LLP Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to the Lead Plaintiff Deadline on September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
Clene Eyes Q4 NDA for ALS Drug After FDA-Requested Biomarker Analyses ↗
Via MarketBeat
Tickers CLNN
Exposures Product Safety
News headline image
Longeveron (LGVN) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Intellectual Property
Tickers LGVN
Exposures Financial Intellectual Property Product Safety
News headline image
Stock Market Today, Aug. 19: Moderna Skyrockets 177% on Positive Phase 3 Melanoma Data ↗
Via The Motley Fool
Topics Stocks
Tickers MRNA PFE
Exposures Product Safety US Equities
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.